Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)verified

SPAGO.ST

Price:

$0.105

Market Cap:

$36.94M

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

Industry

Biotechnology

IPO Date

2013-01-16

Stock Exchange

STO

Ticker

SPAGO.ST

The ROE as of December 2025 (TTM) for Spago Nanomedical AB (publ) (SPAGO.ST) is 5.23%

According to Spago Nanomedical AB (publ)’s latest financial reports and current stock price. The company's current ROE is 5.23%. This represents a change of -117.88% compared to the average of -29.22% of the last 4 quarters.

Spago Nanomedical AB (publ) (SPAGO.ST) Historical ROE (quarterly & annually)

How has SPAGO.ST ROE performed in the past?

The mean historical ROE of Spago Nanomedical AB (publ) over the last ten years is -30.64%. The current 5.23% ROE has changed -117.05% with respect to the historical average. Over the past ten years (40 quarters), SPAGO.ST's ROE was at its highest in in the December 2024 quarter at 0.35%. The ROE was at its lowest in in the September 2025 quarter at -50.71%.

Quarterly (TTM)
Annual

Average

-30.64%

Median

-13.29%

Minimum

-102.19%

Maximum

-8.77%

Spago Nanomedical AB (publ) (SPAGO.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Spago Nanomedical AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 412.55%

Maximum Annual ROE = -8.77%

Minimum Annual Increase = -19.66%

Minimum Annual ROE = -102.19%

Quarterly (TTM)
Annual
YearROEChange
2024-97.82%-4.28%
2023-102.19%412.55%
2022-19.94%-5.70%
2021-21.14%78.60%
2020-11.84%-19.66%
2019-14.74%62.37%
2018-9.08%3.43%
2017-8.77%-16.39%
2016-10.49%1.01%
2015-10.39%-10.81%

Spago Nanomedical AB (publ) (SPAGO.ST) Average ROE

How has SPAGO.ST ROE performed in the past?

The current ROE of Spago Nanomedical AB (publ) (SPAGO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-73.32%

5-year avg

-50.59%

10-year avg

-30.64%

Spago Nanomedical AB (publ) (SPAGO.ST) ROE vs. Peers

How is SPAGO.ST’s ROE compared to its peers?

Spago Nanomedical AB (publ)’s ROE is greater than Sprint Bioscience AB (publ) (-308.32%), less than Alligator Bioscience AB (publ) (113.61%), greater than AcouSort AB (publ) (-92.86%), greater than Lipigon Pharmaceuticals AB (publ) (-192.99%), less than Simris Alg AB (publ) (670.62%), greater than SpectraCure AB (publ) (-47.97%), greater than OncoZenge AB (publ) (-81.33%), greater than Scandinavian Real Heart AB (Publ) (-56.04%), greater than Pila Pharma AB (publ) (-350.68%), greater than Active Biotech AB (publ) (-223.35%),

Build a custom stock screener for Spago Nanomedical AB (publ) (SPAGO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spago Nanomedical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spago Nanomedical AB (publ) (SPAGO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spago Nanomedical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Spago Nanomedical AB (publ)'s ROE?

How is the ROE calculated for Spago Nanomedical AB (publ) (SPAGO.ST)?

What is the highest ROE for Spago Nanomedical AB (publ) (SPAGO.ST)?

What is the 3-year average ROE for Spago Nanomedical AB (publ) (SPAGO.ST)?

What is the 5-year average ROE for Spago Nanomedical AB (publ) (SPAGO.ST)?

How does the current ROE for Spago Nanomedical AB (publ) (SPAGO.ST) compare to its historical average?